ACAD9 deficiency in humans can lead to acute liver dysfunction and hypoglycemia, and deletion of medium chain acyl-CoA dehydrogenase (Acadm), immediately downstream of Acad9 in the mitochondrial long-chain β-oxidation pathway, profoundly affects hepatic glucose metabolism [50]. Here, ACADM is linked to Decreased liver function.